期刊文献+

肿瘤细胞多药耐药的基础和临床研究进展 被引量:4

下载PDF
导出
作者 吴月兵
出处 《肿瘤防治研究》 CAS CSCD 2003年第3期249-251,共3页 Cancer Research on Prevention and Treatment
  • 相关文献

参考文献17

二级参考文献9

  • 1王楠,汤仲明.MTT方法测定培养细胞抗药水平的评价[J].中国药理学通报,1996,12(5):421-424. 被引量:14
  • 2杨纯正.肿瘤耐药研究进展及逆转对策[J].中华血液学杂志,1997,18(2):59-60. 被引量:29
  • 3颜子颍 王海林(译).精编分子生物学实验指南[M].北京:科学出版社,1998.274-328.
  • 4《中药辞海》编写组.中药辞典(第三卷),第1版[M].北京:中国医药科技出版社,1997.789.
  • 5缪金明 沈志祥.肿瘤细胞的药物耐药性.血液肿瘤学[M].北京:人民卫生出版社,1999.72.
  • 6Chang H A,Biochem Pharmacol,1996年,52卷,2期,393页
  • 7Yang J M,Cancer Res,1994年,54卷,3期,730页
  • 8Chu E, Drake JC, Koeller DM.Induction of thymidylate synthase associated with multidrug resistance in human breast andcolon cancer cell lines [ J ]. Mol Pharmacol, 1991,39:136.
  • 9白月辉,黄世林.雄黄对NB_4及HL-60细胞的促凋亡作用[J].中华血液学杂志,1998,19(9):477-480. 被引量:119

共引文献14

同被引文献84

  • 1吴涛,吴志敏,袁先厚.脑胶质瘤化疗多药耐药机制的研究进展[J].肿瘤防治研究,2004,31(8):518-520. 被引量:4
  • 2Agarwala SS, Kirkwood JM, Gore M, et al.Temozolomide for the Treatment of Brain Metastases Associated with Metastatic Melanoma.A Phase Ⅱ Study[J].Journal of clinical Oncology,2004,22(11):2101-2107.
  • 3Ridolfi R, Romanini A, Sileni VC, et al. Temozolomide and interferonalpha in metastatic melanoma:a phaseⅡstudy of the ltalian melanoma lntergroup [J].Melanoma Res,2004,14(4)295-299.
  • 4WenJen Hwu, Eric Lis, Jennifer H.Menell, et al. Temozolomide Plus Thalidomide in Patients with Brain Metastases from Melanoma[J]. Cancer, 2005,103(12),2590-2597.
  • 5Middleton MR, Lunn JM, Morris C, et al. O6-Methylguanine DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma[J]. Br J Cancer, 1998,78(9):1199-1202.
  • 6Juillerat A, JuilleratJeanneret L.Salkylthiolation of O6-methylguanineDNAmethyltransferase (MGMT) to sensitize cancer cells to anticancer therapy [J]. Expert Opin Ther Targets,2007,11(3):349-361.
  • 7Quirt I, Verma S, Petrella T, et al. Temozolomide for the treatment of metastatic melanoma[J]. Oncologist,2007 ,14(1): 27-33.
  • 8Gogas H, Polyzos A, Stavrinidis I, et al. Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group [J]. Annals of Oncology,2006,17(12):1835-1841.
  • 9Wen-Jen Hwu, Katherine S, ennifer H, et al. Phase II study of temozolomide plus pegylated interferon-α-2b for metastatic melanoma[J]. Expert Opin Ther Targets, 2007,11(3):349-361.
  • 10Ridolfi R, Romanini A, Sileni VC,et al. Temozolomide and interferonalpha in metastatic melanoma: a phase II study of the Italian Melanoma Intergroup[J]. Melanoma Res,2004,14(4):295-299.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部